Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Purchases 376,552 Shares of Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management purchased 376,552 shares of Senestech stock in a transaction dated Monday, October 19th. The stock was bought at an average price of $0.70 per share, with a total value of $263,586.40. Following the acquisition, the insider directly owned 2,063,098 shares of the company’s stock, valued at approximately $1,444,168.60. This trade represents a 22.33% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Friday, October 16th, Glenbrook Capital Management acquired 181,252 shares of Senestech stock. The shares were bought at an average cost of $0.63 per share, with a total value of $114,188.76.
• On Thursday, October 15th, Glenbrook Capital Management acquired 426,000 shares of Senestech stock. The shares were bought at an average price of $0.77 per share, for a total transaction of $328,020.00.
• On Friday, August 7th, Glenbrook Capital Management acquired 6,490 shares of Senestech stock. The stock was bought at an average cost of $1.30 per share, for a total transaction of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management acquired 15,000 shares of Senestech stock. The stock was bought at an average cost of $1.30 per share, for a total transaction of $19,500.00.

Senestech Stock Up 8.2%

NASDAQ SNES traded up $0.05 on Monday, reaching $0.70. The company had a trading volume of 1,245,150 shares, compared to its average volume of 375,681. The firm has a market capitalization of $3.79 million, a price-to-earnings ratio of -0.51 and a beta of 0.25. The company has a debt-to-equity ratio of 0.02, a quick ratio of 5.81 and a current ratio of 6.78. Senestech, Inc. has a 1-year low of $0.55 and a 1-year high of $4.04. The company’s fifty day moving average is $0.93 and its 200-day moving average is $1.34.

Senestech (NASDAQ:SNES) last released its earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.02. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. The firm had revenue of $0.77 million during the quarter, compared to analysts’ expectations of $0.60 million. On average, research analysts forecast that Senestech, Inc. will post -1.28 earnings per share for the current fiscal year.

Institutional Trading of Senestech

An institutional investor recently bought a new stake in Senestech stock. Diversify Wealth Management LLC bought a new position in shares of Senestech, Inc. (NASDAQ:SNES) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned about 0.36% of Senestech at the end of the most recent quarter. 5.19% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings downgraded Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, Senestech currently has an average rating of “Sell”.

About Senestech

SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.

SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.